Article Excerpt: NanoMedical Systems has received a nearly $3 million grant from the Department of Defense to develop a combination device for the long-term treatment of opioid use. The Austin-based company develops drug-delivery devices based on its nStrada nanofluidics platform for sustained release (up to six months) of chronic therapies. These devices can be loaded with a variety of drugs including small molecules, peptides, and proteins for subcutaneous implantation.
Full Article: https://tinyurl.com/yd3tz6fn
Article Source: Medical Device and Diagnostic Industry